Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) Interest Coverage Ratio (2024 - 2026)

Updated

Abivax's Interest Coverage Ratio was -1.91 in Q2 2026, compared with -9.19 a year earlier.

Analysis

Abivax (ABVX) Interest Coverage Ratio (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Abivax's Interest Coverage Ratio was -0.01 through Jun 30, 2026; for FY2025, it was -0.01.

  • In earlier years, Interest Coverage Ratio was -0.01 in FY2024, -0.01 in FY2023, -0.01 in FY2022 and -0.01 in FY2021.
  • Quarterly Interest Coverage Ratio has moved between -14.68 (Q1 2024) and 0.00 (Q4 2025) over five years.
  • Per Business Quant data, ABVX's Interest Coverage Ratio in the three quarters before Q2 2026 was -11.79 (Q1 2026), 0.00 (Q4 2025) and -3.09 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 25.41
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 10.28
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 7.27
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 5.22
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -42.08
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Abivax 7.15 Bn 7.15 Bn - -1.91
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.91
Mar 31, 2026 -11.79
Dec 31, 2025 0.00
Sep 30, 2025 -3.09
Jun 30, 2025 -9.19
Mar 31, 2025 -8.88
Dec 31, 2024 -0.01
Sep 30, 2024 -7.50
Jun 30, 2024 -7.18
Mar 31, 2024 -14.68
API Access

Abivax Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=ABVX&period=max&api_key=YOUR_API_KEY